Preventability of Drug-Related Harms – Part I
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference66 articles.
1. Preventability of Drug-Related Harms – Part II
2. Adverse drug reaction monitoring—cost and benefit considerations. Part II: cost and preventability of adverse drug reactions leading to hospital admission
3. Preventable Drug Reactions — Causes and Cures
4. Preventability of Adverse Drug Reactions
5. Development, Testing, and Findings of a Pediatric-Focused Trigger Tool to Identify Medication-Related Harm in US Children's Hospitals
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An analysis of international strategies for monitoring and preventability described in medicinal product information: a study protocol;2024-06-15
2. Management of adverse drug reactions: A review;IP International Journal of Comprehensive and Advanced Pharmacology;2024-03-15
3. Safeguarding human rights to health: a systematic review of supply chain impediments to safe medicines in developing nations;International Journal of Human Rights in Healthcare;2023-08-31
4. Review on Adverse Drug Reactions;International Journal of Advanced Research in Science, Communication and Technology;2023-01-25
5. ADRs and ADEs: Focus on drug-antibody conjugates, pharmacogenomics, and COVID19 vaccines;Side Effects of Drugs Annual;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3